CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer (Q36465344)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer |
scientific article |
Statements
1 reference
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer (English)
1 reference
Kadri Altundag
1 reference
Aman U Buzdar
1 reference
Francisco J Esteva
1 reference
Jing Wang
1 reference
Feng Lin
1 reference
Jaime A Mejia
1 reference
Kai Yan
1 reference
Vicente Valero
1 reference
Gabriel N Hortobagyi
1 reference
W Fraser Symmans
1 reference
Lajos Pusztai
1 reference
1 January 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference